DRKS00025254
Recruiting
Not Applicable
Evaluation of the immune response against COVID-19 in pediatric Cancer patients after vaccination - COV-PEDONK
Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität0 sites100 target enrollmentMay 26, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- eed for vaccination against COVID-19
- Sponsor
- Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients treated for malignoima (both during intensive chemotherapy and in maintenance therapy) up to 3 months after cessation of chemotherapy
- •\- Age 16\-18 years (youngert once the vaccine will be approved for this age Group)
- •\- No contraindication for SARS\-CoV\-2 vaccination
- •\- Written informed consent Patient and caregiver
Exclusion Criteria
- •\- known inborn immunodeficiency
- •\- Prior infection with SARS\-CoV\-2
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Investigating the immune response to COVID-19 vaccination in lung transplantation patients (COVALENT study)NL-OMON22289niversity Medical Center Groningen (UMCG)180
Not yet recruiting
Not Applicable
COVID-19 vaccination of vulnerable populations (COVULPOP)COVID-19 vaccine responseCOVID-19Inflammatory and Immune System - Normal development and function of the immune systemRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12621001492842Prof Katie Flanagan40
Recruiting
Not Applicable
Immune response and therapy assessment to COVID-19 Vaccinations in people with Diabetes Mellitus – an observational pilot studyE10E11Type 1 diabetes mellitusType 2 diabetes mellitusDRKS00024879Division Exercise Physiology and Metabolism60
Recruiting
Not Applicable
EVEREST: Evaluation of COVID-19 Vaccination Efficacy and Rare Events in Solid TumoursACTRN12621001307897The Canberra Hospital200
Completed
Not Applicable
Serological response to COVID-19 and association with MR containing vaccineCTRI/2021/01/030363niversity College of Medical Sciences90